Kevin Murphy co-authored an article with Barry C. Harris, Robert D. Willig, and Mathew B. Wright about FTC v. Actavis, Inc. which appeared in the spring 2014 issue of Antitrust. The article discusses a method of evaluating the competitive effects of reverse payment settlement agreements that was proposed in a recent article in Antitrust, showing that it only holds under limited conditions. To read the article, click below.
What’s 340B? An economist’s view of the recent wave of 340B litigation
But this change has led to complex relationships among pharmaceutical manufacturers, hospitals, pharmacies, and third-party administrators, increasing...